European Commission: President von der Leyen on the authorisation of the contract for vaccines with Pfizer and BioNTech

A safe and effective vaccine is our best chance to beat coronavirus and return to our normal lives.

In the past months, the European Commission has been working tirelessly to secure doses of potential vaccines.

And tomorrow we authorise a contract for up to 300 million doses of the vaccine developed by German company BioNTech and Pfizer. This is the most promising vaccine so far.

Once this vaccine becomes available, our plan is to deploy it quickly, everywhere in Europe. This will be the fourth contract with a pharmaceutical company to buy vaccines. And more will come. Because we need to have a broad portfolio of vaccines based on different technologies.

We have already started working with Member States to prepare national vaccination campaigns.

We are almost there. In the meantime, let us be prudent, and stay safe.


Tags assigned to this article:

You may have an interest in also reading…

European Commission on Coronavirus: Commission proposes to ease restrictions on non-essential travel to the EU while addressing variants through new ‘emergency brake’ mechanism

Today, the Commission is proposing that Member States ease the current restrictions on non-essential travel into the EU to take into account

European Commission on Coronavirus: preparing Europe for the increased threat of variants

Today, the Commission is proposing immediate action to prepare Europe for the increased threat of coronavirus variants. The new European bio-defence

European Commission: Commission disburses €14 billion under SURE to nine Member States

The European Commission has disbursed €14 billion to nine EU countries in the second instalment of financial support to Member